Progress Software Corp. (NASDAQ:PRGS): According to Benchmark Co., the resignation of Progress Software’s CEO Jay Bhatt could be a clue that the company has begun to entertain a possible company sale. The firm believes that there could be additional details to the story, and it reiterates its Buy rating on the stock.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) price target has been increased by Wedbush after an update concerning the launch of Hylenex. Shares have an Outperform rating and are on the Best Idea List.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Green Dot Corporation (NYSE:GDOT) price target has been reduced by Credit Suisse due to increased competitive headwinds. Shares have a Neutral rating.
Marriott International, Inc. (NYSE:MAR) reported higher Q3 EPS than predicted, causing Argus to believe that patient investors will be ultimately awarded by the stock with the recovery of several regions. The firm keeps its Buy rating and a $48 target on the stock.
EZCORP Inc. (NASDAQ:EZPW) shares were defended at Sidoti.
Don’t Miss: Could Vivus’ New Drug Be a Blockbuster?